Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website

Short Communication

Volume 14, Number 4, April 2022, pages 165-169

Participant Perspectives Concerning Resuming Clinical Research in the Era of COVID-19


Figure 1.
Figure 1. (a) Low risk for severe illness related to COVID-19. (b) Prefer to do visits over the phone or internet. (c) Research is important because of the financial incentives. (d) Research is more important than before COVID-19. COVID-19: coronavirus disease 2019.


Table 1. Participant Characteristics*
In-person (N = 251)Online (N = 1,537)P-value
*Some data may be missing due to incomplete surveys. SD: standard deviation; PBRC: Pennington Biomedical Research Center; COVID-19: coronavirus disease 2019.
Age (mean ± SD) (years)55 ± 1858 ± 14< 0.001
Sex (females)56.8%75.2%< 0.0001
Race (White/non-White)69.7%/30.3%74.3%/25.7%0.13
Answered survey as self vs. parent/guardian87.7 vs. 12.3%
Current study type
  Diabetes/diabetes prevention24.5%
  General health and wellbeing12.4%
  Weight loss15.4%
  Women’s health1.2%
  Healthy aging/Alzheimer’s disease36.1%
Previously participated in a study at PBRC40.5%41.9%0.68
Previously had symptoms of COVID-195.2%19.6%< 0.0001
Knew someone who became ill with COVID-1949.4%72.7%< 0.0001